Daniel Patrick Mackey

Chief Financial Officer

Finansinspektionen (Sweden) Files from Sweden

Compiled from cited public records — every figure names the disclosure it came from, none copied from any wealth ranking. How we calculate this.

Positions on file
1
positions reconstructed from transactions reported to Finansinspektionen (FI) in Sweden

Not measurable for this profile: Reconstructed positions · 1-day change

Trading activity Jun 27, 2017 – Mar 15, 2021

Daniel Patrick Mackey reported 9 transactions between Jun 27, 2017 and Mar 15, 2021. The buy and sell totals below count only codes SACQ, SDIS.

Open-market buys (SACQ)
643.8K SEK
7 purchases on file priced rows only
Open-market sales (SDIS)
41.2K SEK
1 sale on file priced rows only
All reported transactions
9
every code, including awards and exercises
Pattern
No transaction in the final 12 months of the window
last 12 months of the window

Reported transactions

Price 0.00 is a real reported figure on allotments, gifts and option exercises — not a missing number. The 9 most recent rows are grouped into 8 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one insider transaction as reported to FI, with a link back to the FI register filtered to that issuer and publication date. FI publishes no per-report permalink, so the link is a search, not a document. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. Infant Bacterial Therapeutics AB SDIS Disposal 400 shares 41.2K SEK at 103.00 SEK FI filing ↗
  2. Infant Bacterial Therapeutics AB SACQ Acquisition × 2 19,812 shares 76.2K SEK
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    19,412 1.77 SEK 34.4K SEK FI filing ↗
    400 104.50 SEK 41.8K SEK FI filing ↗
  3. Infant Bacterial Therapeutics AB SACQ Acquisition 4,294 shares 20.9K SEK at 4.86 SEK FI filing ↗
  4. Infant Bacterial Therapeutics AB SACQ Acquisition 16,294 shares 232.0K SEK at 14.24 SEK FI filing ↗
  5. Infant Bacterial Therapeutics AB SACQ Acquisition 340 shares 41.0K SEK at 120.50 SEK FI filing ↗
  6. Infant Bacterial Therapeutics AB SSUB Subscriptionnot a buy/sell decision 2,459 shares 233.6K SEK at 95.00 SEK FI filing ↗
  7. Infant Bacterial Therapeutics AB SACQ Acquisition 503 shares 52.8K SEK at 105.00 SEK FI filing ↗
  8. Infant Bacterial Therapeutics AB SACQ Acquisition 50,000 shares 221.0K SEK at 4.42 SEK FI filing ↗

Reconstructed positions

Reconstructed by adding up every transaction this person reported to FI since 2016. FI publishes transactions, not balances, so this is a computed figure, not a disclosed one — and it omits anything held before the register began.

What is not counted here

Each row comes from a public disclosure named on this page. Private companies, real estate, bonds and crypto are not in those disclosures and are therefore not counted here. Shares held through a holding company are recorded against that company, not against the individual behind it.

Equity positions reported to Finansinspektionen (FI) in Sweden, with the disclosure date shown on each row.
Issuer ISIN Security Shares Price Value Form Reported Filing
Infant Bacterial Therapeutics AB SE0008015259 IBT B 843 FI marknadssok.fi.se ↗

Other shareholders on record at the same companies

People who also appear on the shareholder record of a company where Daniel Patrick Mackey reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

Every figure on this page is quoted from the public record named beside it, with the date it was true. Nothing here is our own calculation.

Think a number here is wrong? Check the named disclosure and its date against the tables above — how to report it.

Profile record last refreshed Sep 14, 2026.